Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

A Comparative Analysis of Naïve Exosomes and Enhanced Exosomes with a Focus on the Treatment Potential in Ovarian Disorders

Mohammad Mousaei Ghasroldasht
ORCID logo ,
Farzana Liakath Ali
,
Hang-Soo Park
,
Morteza Hadizadeh
,
Shao Huan Samuel Weng
ORCID logo ,
Allen Huff
,
Somayeh Vafaei
ORCID logo ,
Ayman Al-Hendy
* ORCID logo
Version 1 : Received: 29 March 2024 / Approved: 29 March 2024 / Online: 1 April 2024 (09:53:22 CEST)

How to cite: Mousaei Ghasroldasht, M.; Liakath Ali, F.; Park, H.; Hadizadeh, M.; Weng, S.H.S.; Huff, A.; Vafaei, S.; Al-Hendy, A. A Comparative Analysis of Naïve Exosomes and Enhanced Exosomes with a Focus on the Treatment Potential in Ovarian Disorders. Preprints 2024, 2024040003. https://doi.org/10.20944/preprints202404.0003.v1 Mousaei Ghasroldasht, M.; Liakath Ali, F.; Park, H.; Hadizadeh, M.; Weng, S.H.S.; Huff, A.; Vafaei, S.; Al-Hendy, A. A Comparative Analysis of Naïve Exosomes and Enhanced Exosomes with a Focus on the Treatment Potential in Ovarian Disorders. Preprints 2024, 2024040003. https://doi.org/10.20944/preprints202404.0003.v1

Abstract

Exosome-based therapy has emerged as a promising strategy for addressing diverse disorders, indicating the need for further exploration of the potential therapeutic effects of the exosome cargos. This study introduces "enhanced exosomes," a novel type of exosomes developed through a novel cell culture system. These specific exosomes may become potent therapeutic agents for treating ovarian disorders. In this study, we conducted a comparative analysis of the protein and miRNA cargo compositions of enhanced exosomes and naïve exosomes. Our findings revealed distinct cargo compositions in enhanced exosomes, featuring upregulated proteins such as EFEMP1, HTRA1, PAM, RSU1, and SDF4, suggesting their potential for treating ovarian disorders. MicroRNA profiling revealed that miR-1-3p, miR-103a-3p, miR-122-5p, miR-1271-5p, miR-133a-3p, miR-184, miR-203a-3p, and miR-206 are key players in regulating ovarian cancer and chemosensitivity by affecting cell cycle progression, cell proliferation, and cell development. We examined polycystic ovary syndrome and premature ovarian insufficiency and identified altered expression of various miRNAs, such as miR-106a-5p, miR-130b-5p, and miR-130b-3p, for diagnostic insights. This study highlights the potential of enhanced exosomes as new therapeutic agents for women's reproductive health, offering a detailed understanding of the impact of their cargo on ovarian disorders.

Keywords

enhanced exosomes; ovarian cancer; polycystic ovary syndrome; poor ovarian reserve; premature ovarian insufficiency

Subject

Biology and Life Sciences, Other

Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Download PDF Download Supplementary

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0
Get PDF Supplementary Files Cite Share 0
Bookmark BibSonomy Mendeley Reddit Delicious
×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.